Related Experiment Video
Updated: Apr 27, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Thermolabile drugs: pharmacist intervention as a guarantee of cold chain maintenance]
I Ricote-Lobera1, B Santos-Mena2, S Fraile-Gil3
1Residente de Farmacia Hospitalaria. Servicio de Farmacia. Hospital Universitario Severo Ochoa. Leganés. Madrid. España.. isabel_rlobera@hotmail.com.
Objective:
To determine whether pharmacist is able to guarantee cold chain maintenance of thermolabile drugs during transport using the available information in the reception process and to compare these results with those obtained in a subsequent intervention phase, in which the manufacturing laboratories were contacted.
Methods:
Intervention study, prospective and comparative"before-after". It was analyzed the storage conditions during transport of all thermolabile drugs received in a 400-bed hospital for 3 months, excluding those from clinical trials.
Results:
The intervention allowed to ensure cold chain maintenance in 76,5% (n = 488) of received drugs, representing an increase of 41,8% (IC 95% 36,7-46,6%; p < 0,001) compared with the percentage obtained before the intervention.
Conclusions:
The pharmacist isn't able to ensure the cold chain maintenance of received thermolabile drugs without temperature monitoring device (64,6%). Reports requested from laboratories allowed to increase significantly that percentage.
More Related Videos
Related Concept Videos
Drug Product Stability
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Decreased Body Temperature
Pharmaceutical Poisoning: Potential Scenarios
Modified-Release Drug Delivery Systems: Influencing Factors

